Genentech
RITUXAN
Manufacturer:
Genentech
Name:
RITUXAN
HCPCS Code Descriptor:
Injection, rituximab, 10 mg
Category:
J Code
HCPCS:
J9312
NDC(s):
50242-0053-06, 50242-0051-21
Primary Type:
Oncology
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team has identified potential listing errors/discrepancies with the following NDCs:
50242-0051-10
Please contact us regarding potential compendia errors/discrepancies
About:
RITUXAN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9312 is aligned to the drug RITUXAN.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/19
HCPCS Effective Date:
1/1/19
HCPCS Short Description:
Inj., rituximab, 10 mg
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Rituxan-Billing-Coding-for-RA.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation
https://www.gene.com/patients/patient-foundation
